XML 72 R53.htm IDEA: XBRL DOCUMENT v3.24.1
Stock–Based Compensation (Tables)
 12 Months Ended
Dec. 31, 2023
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Schedule of Unrecognized Compensation Expense

Unrecognized compensation expense related to the stock-based compensation awards and equity-based awards as of December 31, 2023 was as follows:

 

   As of December 31, 2023 
   Restricted
Stock		   Common
Stock Options		   ABG Warrants   Totals 
Unrecognized compensation expense  $1,191   $4,192   $26   $5,409 
Weighted average period expected to be recognized (in years)   1.84    1.33    2.01    1.45 
New Publisher Partner Warrant [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Schedule of Exercise Prices of Common Stock Options

The exercise prices of the New Publisher Partner Warrants outstanding and exercisable are as follows as of December 31, 2023.

 

Exercise   Outstanding   Exercisable 
Price   (Shares)   (Shares) 
$5.30    6,800    - 
$10.56    3,000    1,084 
      9,800    1,084 
Schedule of Warrants Activity

A summary of the New Publisher Partner Warrants activity during the year ended December 31, 2023 is as follows:

 

           Weighted 
           Average 
       Weighted   Remaining 
      Average   Contractual 
   Number of   Exercise   Life 
   Shares   Price   (in Years) 
New Publisher Partner Warrants outstanding at January 1, 2023   -   $-    - 
Granted   9,800    6.91    - 
New Publisher Partner Warrants outstanding at December 31, 2023   9,800    6.91    4.15 
New Publisher Partner Warrants exercisable at December 31, 2023   1,084    10.56    3.92 
New Publisher Partner Warrants not vested at December 31, 2023   8,716           
New Publisher Partner Warrants available for future grants at December 31, 2023   23,000           
ABG Warrants [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Schedule of Exercise Prices of Common Stock Options

The exercise prices of the ABG Warrants outstanding and exercisable are as follows as of December 31, 2023.

 

Exercise   Outstanding   Exercisable 
Price   (Shares)   (Shares) 
$9.24    749,655    299,862 
$18.48    249,885    99,954 
      999,540    399,816 
Schedule of Warrants Activity

A summary of the ABG Warrant activity during the year ended December 31, 2023 is as follows:

 

   Number of Shares   Weighted
Average		   Weighted
Average
Remaining
Contractual
Life		 
   Unvested   Vested   Exercise Price   (in years) 
ABG Warrants outstanding at January 1, 2023   599,724    399,816   $11.55    6.46 
Vested   -    -           
ABG Warrants outstanding at December 31, 2023   599,724    399,816    11.55    5.46 
Summary of Stock-based Compensation

Stock–based compensation and equity-based expense charged to operations or capitalized during the years ended December 31, 2023 and 2022 are summarized as follows:

 

   Year Ended December 31, 2023 
   Restricted
Stock		   Common
Stock Options		   ABG Warrants   Totals 
Cost of revenue  $2,092    4,460    10   $6,562 
Selling and marketing   257    1,402    -    1,659 
General and administrative   6,372    3,457    1,010    10,839 
Total costs charged to operations   8,721    9,319    1,020    19,060 
Capitalized platform development   -    1,016    -    1,016 
Total stock-based compensation  $8,721    10,335    1,020   $20,076 

 

 

   Year Ended December 31, 2022 
   Restricted
Stock		   Common
Stock Options		   ABG Warrants   Totals 
Cost of revenue  $3,730   $6,505   $-   $10,235 
Selling and marketing   270    2,502    -    2,772 
General and administrative   9,067    7,776    1,495    18,338 
Total costs charged to operations   13,067    16,783    1,495    31,345 
Capitalized platform development   -    1,884    -    1,884 
Total stock-based compensation  $13,067   $18,667   $1,495   $33,229 
Restricted Stock Units [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Schedule of Restricted Stock Units Activity

A summary of the restricted stock unit activity during the year ended December 31, 2023 is as follows:

 

   Number of Shares   Weighted
Average
Grant-Date		 
   Unvested   Vested   Fair Value 
Restricted stock units outstanding at January 1, 2023   994,766    397,376   $15.44 
Granted   148,970    -    5.77 
Vested   (645,023)   645,023      
Released   -    (429,528)     
Cancelled   (299,446)   -      
Restricted stock units outstanding at December 31, 2023   199,267    612,871    13.55 
Common Equity Awards [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Schedule of Fair Value of Stock Options Assumptions

 

   Years Ended December 31, 
   2023   2022 
   Up-list   Up-list   No Up-list 
Risk-free interest rate   3.46% - 4.82%   0.97% - 4.36%   0.97% - 1.44%
Expected dividend yield   0.00%   0.00%   0.00%
Expected volatility   46.43% - 47.27%   42.00% - 82.00%   82.00% - 137.00%
Expected life   6 years    3.0 – 6.0 years    3.0 – 6.0 years 
Summary of Stock Option Activity

A summary of the common stock option activity during the year ended December 31, 2023 is as follows:

 

           Weighted 
           Average 
       Weighted   Remaining 
      Average   Contractual 
   Number of   Exercise   Life 
   Shares   Price   (in Years) 
Common stock options outstanding at January 1, 2023   6,199,521   $15.26    8.20 
Granted   287,993    4.22      
Exercised   (6,927)   8.82      
Forfeited   (449,333)   9.70      
Expired   (579,286)   9.38      
Common stock options outstanding at December 31, 2023   5,451,968    9.56    4.43 
Common stock options exercisable at December 31, 2023   4,049,393    9.64    5.06 
Common stock options not vested at December 31, 2023   1,402,575           
Common stock options available for future grants at December 31, 2023 (1)   542,847           

 

(1)Common stock available for future issuance under the 2022 Plan represent 1,800,000 of authorized shares; less 1,066,597 common stock options outstanding and 190,556 restricted stock units outstanding.
Common Stock Awards [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Schedule of Exercise Prices of Common Stock Options

The exercise prices under the common stock options outstanding and exercisable are as follows as of December 31, 2023:

 

Exercise   Outstanding   Vested 
Price   (Shares)   (Shares) 
$2.48 to $10.50    4,318,901    3,308,790 
$10.51 to $15.52    1,062,379    670,956 
$15.53 to $20.54    9,091    9,091 
$20.55 to $25.56    25,683    24,642 
$25.57 to $30.58    910    910 
$30.59 to $35.60    4,320    4,320 
$35.61 to $40.62    2,728    2,728 
$40.63 to $48.40    27,956    27,956 
      5,451,968    4,049,393